United Therapeutics | UTHR - Dochód Netto





Dochód Netto Zmiana Data
Amarin USD -1.22M 6.51M 2025-12
Ardelyx USD -407K 562K 2025-12
Baxter International USD -15M 1.11B 2026-03
Bayer EUR 2.76B 6.52B 2026-03
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
Biogen USD 319.5M 368.4M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Gilead Sciences USD 2.02B 162M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Halozyme Therapeutics USD 150.05M 291.64M 2026-03
Insmed USD -163.56M 164.92M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
J&J USD 5.24B 119M 2026-03
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
Moderna USD -1.34B 517M 2026-03
Omeros USD -32.23M 23.81M 2024-09
Pfizer USD 2.69B 4.34B 2026-03
PTC Therapeutics USD -2.81M 132.16M 2026-03
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Teva Pharmaceutical Industries USD 369M 111M 2026-03
United Therapeutics USD 274.9M 89.4M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03